Lipella Pharmaceuticals Inc. Common Stock (LIPO) — Financial Flexibility Index
Lipella Pharmaceuticals Inc. Common Stock (LIPO) has a Financial Flexibility Index of -2734.54x as of September 2025. Free cash flow of $-2.36 Billion (operating CF $-2.36 Billion minus capex $0.00) represents -2735% of total liabilities ($862.22K). Check Lipella Pharmaceuticals Inc. Common Stoc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lipella Pharmaceuticals Inc. Common Stock Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Lipella Pharmaceuticals Inc. Common Stock across 6 annual periods. See Lipella Pharmaceuticals Inc. Common Stoc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lipella Pharmaceuticals Inc. Common Stock (2019–2024)
Year-by-year free cash flow to debt coverage for Lipella Pharmaceuticals Inc. Common Stock. For the full company profile including market capitalisation, see Lipella Pharmaceuticals Inc. Common Stoc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.24x | $-3.95 Million | $-3.95 Million | $754.42K | ▲ +27.7% |
| 2023 | -7.25x | $-3.14 Million | $-3.15 Million | $432.73K | ▼ -404.4% |
| 2022 | -1.44x | $-1.83 Million | $-1.83 Million | $1.27 Million | ▲ +14.4% |
| 2021 | -1.68x | $-989.27K | $-989.27K | $589.34K | ▼ -2788.3% |
| 2020 | -0.06x | $-28.58K | $-28.58K | $491.70K | ▲ +64.7% |
| 2019 | -0.16x | $-39.12K | $-39.12K | $237.26K | — |